Replies to post #382 on Oncolytics Biotech Inc. (ONCY)

[onco_investor]

Updated Investor Presentation Jan 7, 2013

http://oncolytics.s3.amazonaws.com/presentations/25/original.pdf?1353946216

Phase III pfs endpoint up next on H&N cancer
7 ongoing randomized clinical studies - most paid by NCI/NCIC
620 Patients treated to date 530 systemically
45 key US patents (325 worldwide) covering use of viruses to treat cancers
100 Liter manufacturing capacity scale - commercial manufacturing agreement in place with Sigma Aldridge